Tag
$CURA
- Curaleaf's vaporizer receives medical device designation in the European Union
- Curaleaf forced to fork out US$32M for settlement with Michigan cultivator
- Curaleaf secures US$40M credit line as stock slides after Florida ballot
- Curaleaf posts record US$1.2B in sales for fiscal 2021
- Curaleaf expands Arizona presence with US$211M Bloom acquisition
- Curaleaf to raise US$425M from private placement
- First medical cannabis flower hits New York shelves, Curaleaf says
- Curaleaf and Rolling Stone co‑branded weed vapes expanding to three more US states
- Curaleaf now owns Colorado's biggest outdoor grower
- Curaleaf cuts US$67M deal for outdoor Colorado grow
- Harvest Health deal to test Trulieve's industry-leading profits
- Tilray 1.0 quietly discloses first-quarter US$341M loss
- Curaleaf plans to stay on top of US pot boom
- Trulieve Cannabis to buy Harvest Health in US$2.1B mega-deal
- Tilray reduces required shareholder vote count to 1/3 for Aphria merger
- New York legalizes US's most progressive recreational weed market
- Trulieve vies for second place in US pot market
- Curaleaf expands cannabis empire into Europe, posts record Q4 sales
- Why the Georgia Senate runoff could reshape North America's cannabis sector
- Pot stock leaders to consider ahead of US election: BCMI
- Curaleaf reports strong revenue growth despite pandemic setbacks
- Canopy launches CBD website in US despite lack of FDA regulations
- Curaleaf bets big on New Jersey months ahead of legalization vote
- Curaleaf says it's on track to be world's biggest weed company in Q1 report
- 'Huge chunk' of Canada's 383 weed companies won't survive this year: investment banker
- Massachusetts weed market evolving into eastern state heavyweight
- No, cannabis isn't recession proof, analyst says
- Curaleaf reports record Q4, bucks recent trends with hiring spree
- Curaleaf enters Colorado with acquisition of edibles veteran BlueKudu
- Massachusetts' cannabis sales worth over half of entire Canadian market
- Four CBD companies poised to take advantage of U.S. policy shift
- New York Governor promises to legalize recreational cannabis in 2020
- Curaleaf: another American pot company outshining its Canadian rivals
- Bernie Sanders Unveils Ambitious Marijuana Legalization Plan
- Market Capitalization Shrinks by $33.18 Billion For Top 10 Canadian Cannabis Companies Since Legalization
- Curaleaf Launches First Medical Cannabis Flower Products in New York
- Shares of Hexo Surge 11% on Wall Street Analyst's Buy Rating
- Cronos Acquires Owner of CBD Brand Lord Jones for US$300 Million
- Curaleaf Tumbles After FDA Sends Warning on CBD Marketing
- U.S. CBD Sales to Surge Above US$23 Billion by 2023: Brightfield
- Canada's Cannabis Advantage Going up in Smoke, Investors Turn to U.S.
- Columbia Care Inc Begins Trading on the NEO Exchange
- ETF for U.S. Pot Stocks to Begin Trading on April 18
- Why CSE‑Listed Stocks Have an Advantage Over Those on the TSX
- 5 of North America’s Fastest Growing Cannabis Retailers